Hengte Ke

6.1k total citations
56 papers, 5.0k citations indexed

About

Hengte Ke is a scholar working on Biomedical Engineering, Biomaterials and Materials Chemistry. According to data from OpenAlex, Hengte Ke has authored 56 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Biomedical Engineering, 20 papers in Biomaterials and 19 papers in Materials Chemistry. Recurrent topics in Hengte Ke's work include Nanoplatforms for cancer theranostics (43 papers), Nanoparticle-Based Drug Delivery (19 papers) and Ultrasound and Hyperthermia Applications (12 papers). Hengte Ke is often cited by papers focused on Nanoplatforms for cancer theranostics (43 papers), Nanoparticle-Based Drug Delivery (19 papers) and Ultrasound and Hyperthermia Applications (12 papers). Hengte Ke collaborates with scholars based in China, United States and Czechia. Hengte Ke's co-authors include Huabing Chen, Tao Yang, Yibin Deng, Hong Yang, Aijun Zhu, Zhengqing Guo, Jinrui Wang, Yuliang Zhao, Yushen Jin and Xiangliang Yang and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Hengte Ke

56 papers receiving 5.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hengte Ke China 37 3.9k 2.2k 1.6k 1.1k 671 56 5.0k
Zhifei Dai China 29 5.1k 1.3× 2.6k 1.1× 1.6k 1.0× 1.4k 1.3× 698 1.0× 62 6.1k
Shreya Goel United States 39 3.1k 0.8× 1.9k 0.9× 1.8k 1.1× 1.2k 1.0× 681 1.0× 74 5.0k
Zhifei Dai China 42 3.0k 0.8× 1.7k 0.8× 1.5k 0.9× 1.2k 1.0× 714 1.1× 121 4.9k
Yongdoo Choi South Korea 38 2.6k 0.7× 1.9k 0.8× 917 0.6× 1.3k 1.1× 874 1.3× 101 4.6k
Xiuli Yue China 39 3.0k 0.8× 1.7k 0.8× 1.3k 0.8× 1.1k 1.0× 406 0.6× 88 4.7k
Meng Yu China 42 2.6k 0.7× 1.6k 0.7× 1.2k 0.8× 1.6k 1.5× 512 0.8× 100 5.0k
Shouju Wang China 39 4.4k 1.1× 2.8k 1.3× 1.7k 1.1× 1.8k 1.6× 989 1.5× 108 7.0k
Xiangdong Xue China 35 2.2k 0.6× 1.6k 0.7× 1.7k 1.1× 1.5k 1.4× 423 0.6× 116 4.3k
Duyang Gao China 36 2.6k 0.7× 1.8k 0.8× 676 0.4× 965 0.9× 501 0.7× 83 3.7k

Countries citing papers authored by Hengte Ke

Since Specialization
Citations

This map shows the geographic impact of Hengte Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hengte Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hengte Ke more than expected).

Fields of papers citing papers by Hengte Ke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hengte Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hengte Ke. The network helps show where Hengte Ke may publish in the future.

Co-authorship network of co-authors of Hengte Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Hengte Ke. A scholar is included among the top collaborators of Hengte Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hengte Ke. Hengte Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yifan, Li‐Yuan Kang, Jie Luo, et al.. (2025). J-Aggregated indocyanine green-loaded exosomes enable photoactivatable cytoplasmic delivery of STING agonist for targeted pancreatic cancer immunotherapy. Nano Today. 62. 102727–102727. 4 indexed citations
2.
Iqbal, Haroon, Anam Razzaq, Fan Liu, et al.. (2024). A bioinspired doxorubicin-carried albumin Nanocage against aggressive Cancer via systemic targeting of tumor and lymph node metastasis. Journal of Controlled Release. 372. 829–845. 10 indexed citations
3.
Li, Ting, Shuhui Jiang, Ying Zhang, et al.. (2023). Nanoparticle-mediated TRPV1 channel blockade amplifies cancer thermo-immunotherapy via heat shock factor 1 modulation. Nature Communications. 14(1). 2498–2498. 42 indexed citations
4.
Wang, Yuan, Ting Li, Xue Wang, et al.. (2022). Albumin-templated platinum (II) sulfide nanodots for size-dependent cancer theranostics. Acta Biomaterialia. 155. 564–574. 14 indexed citations
5.
Zhai, Yanhua, Ming Liu, Tao Yang, et al.. (2022). Self-activated arsenic manganite nanohybrids for visible and synergistic thermo/immuno-arsenotherapy. Journal of Controlled Release. 350. 761–776. 51 indexed citations
6.
Li, Ting, Mengjuan Li, Jie Luo, et al.. (2022). Holographically Activatable Nanoprobe via Glutathione/Albumin‐Mediated Exponential Signal Amplification for High‐Contrast Tumor Imaging. Advanced Materials. 35(10). e2209603–e2209603. 23 indexed citations
7.
Wang, Yuan, Di Liu, Meng You, Hong Yang, & Hengte Ke. (2022). Liposomal cyanine dyes with enhanced nonradiative transition for the synergistic phototherapy of tumors. Journal of Materials Chemistry B. 10(16). 3016–3022. 10 indexed citations
8.
Guo, Zhengqing, Hui He, Yi Zhang, et al.. (2020). Heavy‐Atom‐Modulated Supramolecular Assembly Increases Antitumor Potency against Malignant Breast Tumors via Tunable Cooperativity. Advanced Materials. 33(2). e2004225–e2004225. 57 indexed citations
9.
Iqbal, Haroon, Tao Yang, Ting Li, et al.. (2020). Serum protein-based nanoparticles for cancer diagnosis and treatment. Journal of Controlled Release. 329. 997–1022. 127 indexed citations
10.
Wen, Ru, Xiaoyan Lv, Tao Yang, et al.. (2017). Albumin nanoreactor-templated synthesis of Gd2O3/CuS hybrid nanodots for cancer theranostics. Science China Materials. 60(6). 554–562. 19 indexed citations
11.
Yang, Tao, Junxing Wang, Qiaoli Wang, et al.. (2017). Size-Tunable Gd2O3@Albumin Nanoparticles Conjugating Chlorin e6 for Magnetic Resonance Imaging-Guided Photo-Induced Therapy. Theranostics. 7(3). 764–774. 73 indexed citations
12.
Qu, Enze, Zhifei Dai, Xiaolong Liang, et al.. (2015). Detection and Pathologic Evaluation of Sentinel Lymph Nodes in the VX2 Tumor Model Using a Novel Ultrasound/Near-Infrared Dual-Modality Contrast Agent. Ultrasound in Medicine & Biology. 41(7). 1905–1912. 6 indexed citations
14.
Wang, Shumin, Zhifei Dai, Hengte Ke, et al.. (2013). Contrast ultrasound-guided photothermal therapy using gold nanoshelled microcapsules in breast cancer. European Journal of Radiology. 83(1). 117–122. 44 indexed citations
15.
Zha, Zhengbao, Shumin Wang, Shuhai Zhang, et al.. (2013). Targeted delivery of CuS nanoparticles through ultrasound image-guided microbubble destruction for efficient photothermal therapy. Nanoscale. 5(8). 3216–3216. 90 indexed citations
16.
Ke, Hengte, Zhifei Dai, Yushen Jin, et al.. (2011). Gold‐Nanoshelled Microcapsules: A Theranostic Agent for Ultrasound Contrast Imaging and Photothermal Therapy. Angewandte Chemie International Edition. 50(13). 3017–3021. 298 indexed citations
17.
Xing, Zhanwen, Jinrui Wang, Hengte Ke, et al.. (2010). The fabrication of novel nanobubble ultrasound contrast agent for potential tumor imaging. Nanotechnology. 21(14). 145607–145607. 128 indexed citations
18.
Xing, Zhanwen, Hengte Ke, Jinrui Wang, et al.. (2010). Novel ultrasound contrast agent based on microbubbles generated from surfactant mixtures of Span 60 and polyoxyethylene 40 stearate. Acta Biomaterialia. 6(9). 3542–3549. 41 indexed citations
19.
Ke, Hengte, Zhanwen Xing, Bo Zhao, et al.. (2009). Quantum-dot-modified microbubbles with bi-mode imaging capabilities. Nanotechnology. 20(42). 425105–425105. 47 indexed citations
20.
Xing, Zhanwen, et al.. (2008). Preparation of Polyelectrolyte Multilayer Coated Microbubbles for Use as Ultrasound Contrast Agent. Chinese Medical Sciences Journal. 23(2). 103–107. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026